125 related articles for article (PubMed ID: 29348517)
41. Platinum resistant cancer cells conserve sensitivity to BH3 domains and obatoclax induced mitochondrial apoptosis.
Crawford N; Chacko AD; Savage KI; McCoy F; Redmond K; Longley DB; Fennell DA
Apoptosis; 2011 Mar; 16(3):311-20. PubMed ID: 21107700
[TBL] [Abstract][Full Text] [Related]
42. ROS mediated ER stress induces Bax-Bak dependent and independent apoptosis in response to Thioridazine.
Seervi M; Rani A; Sharma AK; Santhosh Kumar TR
Biomed Pharmacother; 2018 Oct; 106():200-209. PubMed ID: 29960166
[TBL] [Abstract][Full Text] [Related]
43. EAT/mcl-1, a member of the bcl-2 related genes, confers resistance to apoptosis induced by cis-diammine dichloroplatinum (II) via a p53-independent pathway.
Ando T; Umezawa A; Suzuki A; Okita H; Sano M; Hiraoka Y; Aiso S; Saruta T; Hata J
Jpn J Cancer Res; 1998 Dec; 89(12):1326-33. PubMed ID: 10081494
[TBL] [Abstract][Full Text] [Related]
44. Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies.
Kim H; Rafiuddin-Shah M; Tu HC; Jeffers JR; Zambetti GP; Hsieh JJ; Cheng EH
Nat Cell Biol; 2006 Dec; 8(12):1348-58. PubMed ID: 17115033
[TBL] [Abstract][Full Text] [Related]
45. MiR-519d impedes cisplatin-resistance in breast cancer stem cells by down-regulating the expression of MCL-1.
Xie Q; Wang S; Zhao Y; Zhang Z; Qin C; Yang X
Oncotarget; 2017 Mar; 8(13):22003-22013. PubMed ID: 28423543
[TBL] [Abstract][Full Text] [Related]
46. Role of Mcl-1 in regulation of cell death in human induced pluripotent stem cell-derived cardiomyocytes in vitro.
Guo L; Eldridge S; Furniss M; Mussio J; Davis M
Toxicol Appl Pharmacol; 2018 Dec; 360():88-98. PubMed ID: 30268579
[TBL] [Abstract][Full Text] [Related]
47. Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins.
Willis SN; Chen L; Dewson G; Wei A; Naik E; Fletcher JI; Adams JM; Huang DC
Genes Dev; 2005 Jun; 19(11):1294-305. PubMed ID: 15901672
[TBL] [Abstract][Full Text] [Related]
48. Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis.
Simonin K; N'Diaye M; Lheureux S; Loussouarn C; Dutoit S; Briand M; Giffard F; Brotin E; Blanc-Fournier C; Poulain L
Apoptosis; 2013 Apr; 18(4):492-508. PubMed ID: 23344663
[TBL] [Abstract][Full Text] [Related]
49. NBK/BIK antagonizes MCL-1 and BCL-XL and activates BAK-mediated apoptosis in response to protein synthesis inhibition.
Shimazu T; Degenhardt K; Nur-E-Kamal A; Zhang J; Yoshida T; Zhang Y; Mathew R; White E; Inouye M
Genes Dev; 2007 Apr; 21(8):929-41. PubMed ID: 17403773
[TBL] [Abstract][Full Text] [Related]
50. Hierarchical involvement of Bak, VDAC1 and Bax in cisplatin-induced cell death.
Tajeddine N; Galluzzi L; Kepp O; Hangen E; Morselli E; Senovilla L; Araujo N; Pinna G; Larochette N; Zamzami N; Modjtahedi N; Harel-Bellan A; Kroemer G
Oncogene; 2008 Jul; 27(30):4221-32. PubMed ID: 18362892
[TBL] [Abstract][Full Text] [Related]
51. NDRG2 suppresses proliferation, migration, invasion and epithelial-mesenchymal transition of esophageal cancer cells through regulating the AKT/XIAP signaling pathway.
Yang CL; Zheng XL; Ye K; Ge H; Sun YN; Lu YF; Fan QX
Int J Biochem Cell Biol; 2018 Jun; 99():43-51. PubMed ID: 29530788
[TBL] [Abstract][Full Text] [Related]
52. Caspase-3 feedback loop enhances Bid-induced AIF/endoG and Bak activation in Bax and p53-independent manner.
Guo W; Zhang Y; Ling Z; Liu X; Zhao X; Yuan Z; Nie C; Wei Y
Cell Death Dis; 2015 Oct; 6(10):e1919. PubMed ID: 26469967
[TBL] [Abstract][Full Text] [Related]
53. Modulation of Mcl-1 transcription by serum deprivation sensitizes cancer cells to cisplatin.
Senichkin VV; Kopeina GS; Prokhorova EA; Zamaraev AV; Lavrik IN; Zhivotovsky B
Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):557-566. PubMed ID: 29203282
[TBL] [Abstract][Full Text] [Related]
54. NDRG2-mediated Modulation of SOCS3 and STAT3 Activity Inhibits IL-10 Production.
Lee EB; Kim A; Kang K; Kim H; Lim JS
Immune Netw; 2010 Dec; 10(6):219-29. PubMed ID: 21286383
[TBL] [Abstract][Full Text] [Related]
55. Accumulation of the pro-apoptotic factor Bak is controlled by antagonist factor Mcl-1 availability.
Minet E; Cosse JP; Demazy C; Raes M; Michiels C
Apoptosis; 2006 Jun; 11(6):1039-47. PubMed ID: 16547591
[TBL] [Abstract][Full Text] [Related]
56. NDRG2 promotes myoblast proliferation and caspase 3/7 activities during differentiation, and attenuates hydrogen peroxide - But not palmitate-induced toxicity.
Anderson KJ; Russell AP; Foletta VC
FEBS Open Bio; 2015; 5():668-81. PubMed ID: 26380811
[TBL] [Abstract][Full Text] [Related]
57. NDRG2 Promotes GATA-1 Expression through Regulation of the JAK2/STAT Pathway in PMA-stimulated U937 Cells.
Kang K; Jung H; Nam S; Lim JS
Immune Netw; 2011 Dec; 11(6):348-57. PubMed ID: 22346774
[TBL] [Abstract][Full Text] [Related]
58. AKT inhibitor suppresses hyperthermia-induced Ndrg2 phosphorylation in gastric cancer cells.
Tao Y; Guo Y; Liu W; Zhang J; Li X; Shen L; Ru Y; Xue Y; Zheng J; Liu X; Zhang J; Yao L
Braz J Med Biol Res; 2013 Apr; 46(4):394-404. PubMed ID: 23558861
[TBL] [Abstract][Full Text] [Related]
59. Low NDRG2, regulated by the MYC/MIZ-1 complex and methylation, predicts poor outcomes in DLBCL patients.
Wu S; Zhang J; Chen S; Zhou X; Liu Y; Hua H; Qi X; Mao Y; Young KH; Lu T
Ann Hematol; 2024 Jun; ():. PubMed ID: 38842567
[TBL] [Abstract][Full Text] [Related]
60. NDRG2 inhibits pyruvate carboxylase-mediated anaplerosis and combines with glutamine blockade to inhibit the proliferation of glioma cells.
Wang J; Sun X; Wang J; Zhang K; Yuan Y; Guo Y; Yao L; Li X; Shen L
Am J Cancer Res; 2022; 12(8):3729-3744. PubMed ID: 36119843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
